About CytoJournal |Editorial Board | Archived articles | Search CytoJ Articles | Subscribe | Peer review policies
  Reviewer corner | Author corner | OA Steward’s corner | CF member’s corner | Join as CF member | Manuscript submission | Open Access (OA) Advocacy
Home
CytoJournal All 'FULL TEXT' in HTML are FREE under "open access" charter of CytoJournal.
To login for downloading any PDF OR to request TOC (Table of Content) by e-mail, please click here
Home Email this page Print this page Small font size Default font size Increase font size Cytopathology Foundation
Navigate here
  Search
 
 » Next article
 » Previous article 
 » Browse articles
  
Resource links
 »  Similar in PUBMED
 »  Search Pubmed for
 »  Search in Google Scholar for
 »  Article in PDF (1,640 KB)
 »  Citation Manager
 »  Access Statistics
 »  Reader Comments
 »  Email Alert *
 »  Add to My List *
* Registration required (free)  

 
  In this article
 »  Abstract
 »  Background
 »  Materials and me...
 »  Results
 »  Discussion
 »  Abbreviations
 »  Authors' contrib...
 »  Acknowledgements
 »  References
 »  Article Figures
 »  Article Tables

 Article Access Statistics
    Viewed22141    
    Printed87    
    Emailed0    
    PDF Downloaded466    
    Comments [Add]    
    Cited by others 25    

Recommend this journal

 


 
RESEARCH
CytoJournal 2006,  3:14

ASC-H in Pap test--definitive categorization of cytomorphological spectrum


1 Department of Pathology, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA, USA
2 Department of Pathology, Medical College of Wisconsin, Milwaukee, WI, USA

Date of Submission13-Nov-2005
Date of Acceptance10-May-2006
Date of Web Publication10-May-2006

Correspondence Address:
Mamatha Chivukula
Department of Pathology, Magee-Womens Hospital of University of Pittsburgh Medical Center, Pittsburgh, PA
USA
Login to access the Email id

© 2006 Chivukula et al; licensee Cytopathology Foundation Inc.This is an open-access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


DOI: 10.1186/1742-6413-3-14

PMID: 16686950

Get Permissions

 » Abstract 

Objective: The American Society for Colposcopy and Cervical Pathology (ASCCP) guidelines for management of ASC-H is colposcopic examination followed by biopsy. HPV testing (HPVT) is recommended after a negative biopsy result. More definitive interpretation of ASC-H could prevent discomfort and minimize the cost. The purpose of this study was to evaluate association of various cytomorphological patterns of ASC-H with various clinical scenarios.
Methods: We reviewed SurePath™ (TriPath Imaging, Inc. Burlington, NC, USA) cervical smears interpreted as ASC-H in 161 women (mean age, 37 {15 to 78} years), over 24 months (2002 to 2003). HPVT (Digene, Hybrid Capture® II HPV test, Digene Corporation, Gaithersburg, MD, USA) was performed in 20% of cases (33/161) and biopsy results were available in 54 cases (19 with and 35 without HPVT).
Results: HPVT was positive in 64% (21/33) cases, and negative in 36% (12/33) cases. In the follow-up biopsies of 71% (15/21) of cases with positive HPVT, 27% showed HPV changes or CIN1, 27% showed CIN2-3, and 46% were negative for epithelial abnormality. Follow-up biopsies from cases with negative HPVT (33%, 4/12 cases), 8% showed CIN1 and 25% were negative for any epithelial abnormality. Six cytomorphological patterns of ASC-H correlated with different clinical categories in relation to HPVT and biopsy results. 35% (19 out of 54 ASC-H cases in which biopsy results were available) could be interpreted definitively as HSIL by cytopathology, 11% (6/54) cases as LSIL with cyanophilic atypical parakeratotic pattern, and 31% (17/54) cases as reactive, with HPV status. The interpretation had to be continued as ASC-H in 22% (12/54) cases.
Conclusion: ASC-H demonstrated a spectrum of cytomorphological patterns. Some of these patterns in liquid-based cervical smears may be more specifically interpreted as LSIL, HSIL, or benign if HPV status is known.



How to cite this article:
Chivukula M, Shidham VB. ASC-H in Pap test--definitive categorization of cytomorphological spectrum. CytoJournal 2006;3:14

How to cite this URL:
Chivukula M, Shidham VB. ASC-H in Pap test--definitive categorization of cytomorphological spectrum. CytoJournal [serial online] 2006 [cited 2014 Apr 19];3:14. Available from: http://www.cytojournal.com/text.asp?2006/3/1/14/41236



 » Background Top


'Atypical squamous cells- cannot exclude HSIL' (ASC-H) was recognized in 2001 Bethesda System [1,2] and [3]. The previous category of ASCUS was replaced by (a) 'ASC of undetermined significance' (ASC-US) and (b) ASC-H [1,2]. This new category includes cases with atypical squamous cells that exhibit some equivocal features suggestive of but not sufficient to call HSIL. The cytomorphological criteria that can be applied for interpretation of this category are not well defined in the literature in general with most of the methods including liquid based cytology (LBC) techniques such as SurePath™ (Tri Path Imaging, Inc, Burlington, NC, USA) and many newly described alternatives [4].

Although relatively an uncommon interpretation, they are associated clinically with significant lesions in the cervical biopsies [6,7] and also anal canal lesions [16,17]. The guidelines of American Society for Colposcopy and Cervical Pathology [11] for management of ASC-H in cervical smears are colposcopic examination followed by biopsy confirmation. If a lesion is not identified on colposcopic examination, the cervical smear is reviewed again followed by a repeat cervical smear at 6 or 12 months or HPV-DNA testing (HPVT) at 12 months.

The purpose of our study is to evaluate various cytomorphological patterns observed in cervical smears previously interpreted and reported as ASC-H in SurePath™ LBC. Different cytomorphological patterns were correlated with reference to results of HPVT (Digene, Hybrid capture ® II HPV test, Digene Corporation, Gaithersburg, Maryland, USA) and biopsy findings. We analyzed if HPV status through HPVT results could be used as an ancillary test to help categorize different cytomorphological patterns more specifically after initial ASC-H interpretation.


 » Materials and methods Top


A total of 161 cases with cytological interpretation of ASC-H in SurePath™ liquid-based cervical cytology smears over a period of 24 months (2002-2003) were studied. The mean age of women in the study was 37 (range 15-78) years. HPVT was performed on remaining specimens in 33 (21%) cases. The respective cervical biopsies obtained synchronously or within 3 months of cervical smear collection of cervical smears were identified, reviewed and correlated in 54 (34%) cases. Our cytology laboratory processes pap tests from our own hospital as well as outside clinics. Since the outside clinics did not send their biopsies to our lab, we could not correlate biopsy results in all cases.

Based on the presence or absence of CIN 2, CIN 3 or above in the biopsies and the status of HPVT results, all the cases were grouped into 6 clinicopathological categories [Table 1]. A) Biopsy positive for CIN 2, CIN 3 or above (BPHSIL) HPVT positive B) biopsy negative for CIN 2, CIN 3 or above (BNHSIL), HPVT positive C) biopsy positive for CIN 2, CIN 3 or above (BPHSIL), HPVT negative D) biopsy negative for CIN 2, CIN 3 or above (BNHSIL), HPVT negative E) biopsy positive for CIN 2, CIN 3 or above (BPHSIL) HPVT not done F) biopsy negative for CIN 2, CIN 3 or above (BNHSIL), HPVT not done.

The cytomorphological features in all cervical smears interpreted as ASC-H were evaluated retrospectively in conjunction with the results of cervical biopsies and HPVT results. A trend in association of various cytomorphological patterns was observed in relation to above-mentioned six clinicopathological categories [Table 2],[Table 1].


 » Results Top


HPVT results were positive in 64% (21/33) cases. Out of these 21 cases with positive HPVT, biopsies were available in 15 cases which showed HPV changes or CIN-1 in 27% (4/15), CIN 2-3 in 27% (4/15), and negative for dysplasia in 47% (3/15) cases. HPVT was negative in 36% (12/33) cases. Out of these 12 HPVT negative cases, biopsies were available in 4 cases which showed CIN-1 in 25 % (1/4) and negative for dysplasia in 75% (3/4).

Out of 128 cases without HPVT, cervical biopsies were available in 35 cases (27.3%). The biopsies in these cases showed CIN-1 in 27% (13/35), CIN 2-3 in 11% (4/35), and negative for dysplasia in 51 % (18/35) cases.

Six cytomorphological patterns [] were correlated with 6 different clinico-pathological categories A through F [Table 1] and a trend in their association was observed [Table 2]. Reactive cytomorphological patterns 1, 2, &3 were associated with categories D & F with negative biopsy results. Dysplastic patterns 5, 6, &7 were associated with categories A & E with positive biopsy (for HPV and/or dysplasia).

The reactive cytomorphological patterns [Table 2],[Table 1] included MGH-like , repair- like , or atrophy-like patterns. MGH-like pattern [Figure 1] showed groups of immature squamous metaplastic cells arranged in a checkerboard pattern [5]. The cells had dark nuclei with open chromatin. Nucleoli may be present. Normoblast-like apoptosis with apoptotic fragments of karyorrhectic nucleus may be observed in area corresponding with the nucleus in some metaplastic cells [5]. The repair-like pattern [Figure 2] showed cohesive clusters of cells with prominent nucleoli and streaming school of fish like pattern. The atrophy-like pattern [Figure 3] showed either single-cell pattern or hyperchromatic crowded groups (HCG) of para-basal cells . In the single cell pattern [Figure 3A], the individual cells had abundant blue cytoplasm, open chromatin with or without nucleoli. On the other hand groups of parabasal cells as HCG [Figure 3B] showed small dark nuclei and variable cytoplasm usually with low N/C ratio. The chromatin was dark but not clumped.

ASC-H: NOS pattern did not show any specific cytological features, but showed atypical squamous cells with high N/C ratio and hyperchromatic nuclei with coarse chromatin.

Six cases with cyanophilic atypical parakeratosis (CAPK) pattern [Table 2], pattern 5, [Figure 5] showed cohesive HCG of immature, relatively small, metaplastic cells with high nuclear to cytoplasmic ratio and relatively cyanophilic staining pattern. Some showed koilocytosis. The cell margins in the group were relatively well seen and were angulated as compared to ill defined curved round cell margins at the periphery in high-grade cells with syncytial pattern. The cervical biopsies showed HPV cytopathic effect with or without mild dysplasia in 3 of these 6 cases.

The HSIL like pattern [Figure 6] showed either single-cell pattern or syncytial pattern . The ASC-H with syncytial pattern [Figure 6A] showed vague syncytial groups of dysplastic cells, which may show focal single cell apoptosis with randomly scattered apoptotic bodies in the apoptotic cells [5]. The nuclear features included hyperchromasia, coarse chromatin, and absence of nucleoli.

ASC-H with HSIL-like pattern of singly scattered cells [Figure 6B] showed isolated single cells similar to 'litigation cells'. These cells with high N/C ratio showed hyperchromatic nuclei without nucleoli.


 » Discussion Top


ASC-H is a new category included in the Bethesda Classification 2001 under the epithelial cell abnormalities [2]. It includes approximately 5-10% of previous ASC-US cases and mimics of HSIL [1,6]. Several previous studies have shown that the positive predictive value for detection of high-grade dysplasia in this group is significantly higher than with ASC-US group [9, 12, 13].

Selvaggi et al reported 68% of high-grade dysplasia in follow-up cervical biopsies in cases with ASC-H [6]. Ali et al reported 48% CIN-1 and 51% CIN 2-3 out of 257 cervical smears with ASC-H, of which 72 had follow-up biopsies [9]. In another study Raab et al reported 26% of high-grade dysplasia detected in the follow-up biopsies of all the cervical smears with ASC-H [12]. The variation in cytohisto correlation pattern reported by different studies may be due to many factors including level of threshold applied to interpret the cytomorphological features as ASC-H or HSIL in a particular lab. These studies further highlight the challenges due to lack of well-defined cytomorphological criteria for ASC-H interpretation.

This suggests a need for well defined specific cytomorphological criteria to help categorize such cervical smears as ASC-H. A very few studies in literature describe the cytomorphological features associated with ASC-H interpretation. Our attempt in this paper is to study the cytomorphology of all the smears interpreted as ASC-H to get a better understanding of the various patterns associated with it. Shidham et al have reported that metaplastic pattern associated with microglandular hyperplasia may lead to ASC-H interpretation [5]. In a study by Selvaggi et al, the most commonly reported findings as ASC-H were atypical squamous metaplastic cells and disorganized HCG [6].

In our study, review of various cytomorphological features [] in LBC smears with reference to different clinico-pathological categories [Table 1] revealed a pattern of association [Table 2].

The cytomorphological features observed in category D (with BNHSIL and negative HPVT) and category F (with BNHSIL) showed benign reactive patterns such MGH-like pattern demonstrating dyshesive cells in checker-board groups [1, pattern 1, [Figure 1]]; repair-like pattern with streaming groups of cells [2, pattern 2, [Figure 2]]; and atrophy-like pattern with hyperchromatic crowded groups of parabasal cells [1, pattern 3 A&B, Figures A&B]. While none in this clinical category showed cyanophilic atypical parakeratosis (pattern 5), HSIL synticial (pattern 6), HSIL single-cell patterns [Table 2].

On the other hand syncytial groups of cells with high N/C ratio with focal individual cell apoptosis could be interpreted as high-grade intraepithelial neoplasia [1, pattern 6B, [Figure 6B]]. Rare cases showed some of these cells as rare single cells [1, pattern 6A, [Figure 6A]]. This pattern was observed in association with cases with CIN2-CIN3 or above in biopsy, i.e. categories A (BPHSIL and HPVT positive) and E (BPHSIL, HPVT negative).

The term 'atypical parakeratosis' (APK) was described in original Bethesda classification under the ASCUS/SIL category as three-dimensional clusters that demonstrated the cellular pleomorphism with caudate or elongated shapes with increased N/C ratio or hyperchromasia. In conventional smears, these groups usually show significant orangeophilia and usually have a differential diagnosis with LSIL. We observed similar groups in SurePath LBC initially interpreted as ASC-H. However, these groups were usually cyanophilic with rare or none orangeophilic cells. In general, the cells in SurePath LBC preparations shrink and appear smaller than conventional smears and so the cells in these groups also appear small. These cyanophilic groups with relatively small cells overlap in morphology with HSIL. They were interpreted as ASC-H and showed association with HPV or CIN1 in biopsy with positive HPVT. This pattern may be categorized as ASC-H, favor HPV . Usual atypical parakeratosis encompasses low-grade differential diagnosis; however, in SurePath LBC some of these groups overlapped in morphology with HSIL, leading to ASC-H interpretation. As most of these groups were cyanophilic, a terminology 'cyanophilic atypical parakeratosis' (CAPK) [1, pattern 5, [Figure 5]], is used in this article to differentiate them from 'atypical parakeratosis in conventional smears with LSIL differential diagnosis.

Role of HPV-DNA testing in ASC-H cases

According to ASCCP guidelines [8] HPVT for high-risk (oncogenic) HPV is recommended in cases with ASC-US. On the other hand the recommended management of ASC-H is colposcopy. Studies have reported association with high-risk HPV in 37.5% [13] to 71% [14] of ASC-H cases. The ASCUS-LSIL Triage Study (ALTS) observed an association of ASC-H with positive HPVT and high-grade lesion (biopsy showing CIN-2 or above) in 30-40% cases, which is higher than with usual ASCUS (10-15% high grade) [1]. This study showed that positive HPVT correlated with ASC-H patterns associated with positive biopsy results [Table 2]. Thus in future HPVT may be applied in similar fashion to that of ASCUS and it may be ordered reflexly in all ASC-H cases.

Other important aspect of the finding of this study is that HPVT results may be applied to modify the preliminary ASC-H interpretation, although this is not usual recommended role of HPVT as compared to ASCUS. In this study, reactive and atrophic ASC-H patterns were associated with negative HPVT. In contrast, ASC-H patterns with LSIL-HSIL on biopsy showed higher chance of positive HPVT [Table 2]. In future, in-situ hybridization may be performed to identify the viral genome in the abnormal ASC-H cells. This may be performed [2] directly on parallel smears or directly on the de-stained smears showing ASC-H at initial interpretation to confirm the HPV status of the abnormal cells under question. Recently reported immuno marker p16 INK4 may also be incorporated for definitive interpretation of ASC-H with relevant precautions by avoiding pitfall of interpreting non-nuclear immunostaining as significant [18,19].

In summary, this study identified a cytomorphologic spectrum (1, [Figure 1] through 6) associated with ASC-H interpretations in SurePath LBC preparations in our laboratory, which demonstrated a pattern with biopsy and HPVT results [Table 2].

Six cytomorphological patterns in association with 6 clinico-pathological categories endorses that ASC-H is not a homogeneous category. A blinded study in future may refine the observations of this study. The patterns ranged from reactive to indeterminate (NOS) to dysplasia [Table 2], [Figure 1] through 6]. If HPVT is negative and ASC-H pattern resembles one of the reactive patterns [Table 2], the findings may be interpreted definitively as reactive with a note-recommending follow-up. Similarly, if HPVT is positive for high risk HPV and ASC-H pattern is more close to that of dysplastic type, the case could be interpreted as HSIL. HPVT positivity with atypical parakeratosis pattern may be interpreted definitively as LSIL or ASC-H favor LSIL. Any other combination where the results of HPVT and the cytomorphological features are not in congruency may be continued as ASC-H- NOS.


 » Abbreviations Top


ASC, Atypical squamous cells; APK, Atypical parakeratosis, ASC-H, Atypical squamous cells- cannot exclude high-grade squamous intraepithelial lesion; ASC-US, Atypical squamous cells of undetermined significance; BNHSIL, biopsy negative for CIN 2, CIN 3 or above; BPHSIL, biopsy positive for CIN 2, CIN 3 or above; CAPK, Cyanophilic atypical parakeratosis; HCG, hyperchromatic crowded groups; HPVT, HPV-DNA testing; HSIL, high grade squamous intraepithelial lesion; LBC, liquid-base cytology; LSIL, low grade squamous intraepithelial lesion. BPHSIL, biopsy positive for CIN 2, CIN 3 or above, BNHSIL, biopsy negative for CIN 2, CIN 3 or above.


 » Authors' contributions Top


  1. (MC) Cytopathology fellow, collected all the data, participated in cytological evaluation, and drafting of manuscript.
  2. (VS) Mentor, conceptual organization, cytological-histological evaluation, and manuscript writing.



 » Acknowledgements Top


  1. CytoJournal thanks the academic editor of this manuscript: Dr. Suzanne Selvaggi, MD, Professor, University of Wisconsin Hospital &Clinics, Madison, WI, United States sselvaggi@facstaff.wisc.edu sselvaggi@facstaff.wisc.edu for organizing and completing the blinded peer-review process for this manuscript.
  2. This study was presented in part as platform at XV International Congress of Cytology, Santiago, and Chile 11-14 April 2004.


 
 » References Top

1.Apgar BS, Zoschnick L, Wright TC Jr: The 2001 Bethesda System Terminology. Am FAM Physician 68 (10) : 1992-1998. 2003 Nov 15   Back to cited text no. 1    
2.The Bethesda System Web site Atlas using the 2001 Bethesda System terminology [http://www.cytopathology.org/NIH/]   Back to cited text no. 2    
3.Nayar R, Solomon D: Second edition of 'The Bethesda Systemfor reporting cervical cytology' - atlas, website, and Bethesda interobserver reproducibility project. Cytojournal 1 (1) : 4. 2004 Oct 21   Back to cited text no. 3    
4.Garbar C, Mascaux C, Fontaine V: Efficiency of aninexpensive liquid- based cytology performed by cytocentrifugations:a comparative study using the histology as reference standard. [http://www.cytojournal.com/content/2/1/15] Cytojournal 2 (1) : 15. 2005 Sep 15   Back to cited text no. 4    
5.Shidham VB, Rao RN, Machhi J, Chavan A: Microglandular hyperplasia has a cytomorphological spectrum overlapping with atypical squamous cells-cannot rule out high-grade squamous intraepithelial lesion (ASC-H). Diagn cytopathol 2004, 30 (1) : 57-61.   Back to cited text no. 5    
6.Selvaggi SM: Reporting of atypical squamous cells, cannot exclude a high-grade squamous intraepithelial lesion (ASC-H) on cervical samples: is it significant? Diagn Cytopathol 2003, 29 (1) : 38-41.   Back to cited text no. 6    
7.Louro AP, Roberson J, Eltoum I, Chhieng DC: Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion. A follow-up study of conventional and liquid based preparations in high-risk population. Am J Clin Pathol 2003, 120 (3) : 392-397.   Back to cited text no. 7    
8.Nayar R, Tabbara SO: Atypical squamous cells: Update on current concepts. Clin Lab Med 2003, 23 (3) : 605-32. Review   Back to cited text no. 8    
9.Alli PM, Ali SZ: Atypical squamous cells of undetermined significance - rule out high-grade squamous intraepithelial lesion: cytopathlogic characteristics and clinical correlates. Diagn Cytopathol 2003, 28 (6) : 308-12.   Back to cited text no. 9    
10.Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: ASCCP -sponsored consensus conference: 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 287 (16) : 2120-9. 2002 Apr 24; Review   Back to cited text no. 10    
11.American Society for Colposcopy and cervical Pathology (ASCCP) guidelines   Back to cited text no. 11    
12.Mahood LK, Raab S: histologic follow-up of pap tests with a diagnosis of Atypical Squamous cells, cannot exclude high-Grade squamous intraepithelial Lesion (ASC-H), American society of Cytopathology, [Abstract only]. 2003, 938.   Back to cited text no. 12    
13.Rowe LR, Aldeen W, Bentz JS: Prevalence and typing of HPV DNA by Hybrid Capture II in Women with ASCUS, ASC-H, LSIL, AGC on Thin prep® Pap tests. Diagn Cytopathol 2004, 30 (6) : 426-32.   Back to cited text no. 13    
14.Lu DW, Pirog EC, Zhu X, Wang HL, Pinto KR: Prevalence and typing of HPV DNA in atypical squamous cells in pregnant woman. Acta Cytologica 2003, 7 (6) : 1008-16.   Back to cited text no. 14    
15.Pirog EC, Erroll M, Harigopal M, Centeno BA: Comparison of Human Papilloma virus DNA prevelance in ASCUS subcategories as defined by original Bethesda 1991 and the new TBS 2001. Arch Pathol Lab Med 2004, 128 (5) : 527-32.   Back to cited text no. 15    
16.Arain S, Walts AE, Thomas P, Bose S: The Anal Pap smear:Cytomorphology of squamous intraepithelial lesions. [http://www.cytojournal.com/content/2/1/4] Cytojournal 2 (1) : 4. 2005 Feb16   Back to cited text no. 16    
17.Leiman G: Anal screening cytology. Cytojournal 2 (1) : 5. 2005 Feb 16; Free full text available at http://www.cytojournal.com/content/2/1/5. Free full text available at http://www.cytojournal.com/content/2/1/4   Back to cited text no. 17    
18.Kotov P, Parameswaran L, Parisi JA, Chivukula M, Cafaro A, Fuentes M, Shidham VB: Application of p16 INK4A Immunostaining for Definitive Interpretation of ASC-H in Liquid Based Cervical Cytology Smears with SurePath ® . Modern Pathology Abstract no. 306 2005, 18 (Supplement 1) : 1a-358a.   Back to cited text no. 18    
19.Pantanowitz L, Cao QJ, Goulart RA, Otis CN: Diagnostic utility of p16 immunocytochemistry for Trichomonas in urine cytology. [http://www.cytojournal.com/content/2/1/11/] Cytojournal 2 (1) : 11. 2005 Jun 29  Back to cited text no. 19    


    Figures

  [Figure 1], [Figure 2], [Figure 3], [Figure 3A], [Figure 3B], [Figure 5], [Figure 6A], [Figure 6B], [Figure 6]
 
 
    Tables

  [Table 1], [Table 2]

This article has been cited by
1 Evaluation of the Oncogenic Human Papillomavirus DNA Test with Liquid-Based Cytology in Primary Cervical Cancer Screening and the Importance of the ASC/SIL Ratio: A Belgian Study
Xavier Catteau,Philippe Simon,Jean-Christophe Noël
ISRN Obstetrics and Gynecology. 2014; 2014: 1
[Pubmed]
2 Follow up of Atypical Squamous Cell Pap Smears in Iraqi Women
Intisar S. Pity,Maida Y. Shamdeen,Shawnim A. Wais
Asian Pacific Journal of Cancer Prevention. 2012; 13(7): 3455
[Pubmed]
3 Should LSIL-H be a distinct cytology category?
Haijun Zhou,Mary R. Schwartz,Donna Coffey,Debora Smith,Dina R. Mody,Yimin Ge
Cancer Cytopathology. 2012; 120(6): 373
[Pubmed]
4 Cervical cytology of atypical squamous cells, cannot exclude high-grade squamous intra-epithelial lesion: significance of age, human papillomavirus DNA detection and previous abnormal cytology on follow-up outcomes
Chang Ohk Sung, Young Lyun Oh, Sang Yong Song
European Journal of Obstetrics & Gynecology and Reproductive Biology. 2011;
[VIEW]
5 Clinical importance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion (LSIL-H)" terminology for cervical smears: 5-Year analysis of the positive predictive value of LSIL-H compared with ASC-H, LSIL, and HSIL in the detection of high-grade cervical lesions with a review of the literature
Ince, U., Aydin, O., Peker, O.
Gynecologic Oncology. 2011; 121(1): 152-156
[Pubmed]
6 Clinical significance of low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion as a squamous abnormality category in cervical cytopathology
Li, X.-F., Li, Y.-Q., Zhang, L.-L.
Tumor. 2011; 31(2): 136-140
[Pubmed]
7 LSIL/ASC-H (LSIL-H) in cervicovaginal smear: Histopathological outcomes and clinical significance
Işik Kaygusuz, E., Çetiner, H., Şahin, D.
Turk Patoloji Dergisi/Turkish Journal of Pathology. 2011; 27(1): 46-50
[Pubmed]
8 Atypical Squamous Cells, Cannot Exclude High-Grade Squamous Intraepithelial Lesion : Review of Ancillary Testing Modalities and Implications for Follow-up
Diane Davis Davey, David L. Greenspan, Daniel F. I. Kurtycz, Mujtaba Husain, R. Marshall Austin
Journal of Lower Genital Tract Disease. 2010; 14(3): 206
[VIEW]
9 The value of duplicate slides on atypical squamous cells, cannot exclude high-grade intraepithelial lesion
Songlin Zhang, Brandi Kelly, Elizabeth Hospodar, Joel Thibodeaux, Jaiyeola Thomas, Fleurette Abreo
Diagnostic Cytopathology. 2010; : n/a
[VIEW]
10 Cytology and outcome of LSIL: cannot exclude HSIL compared to ASC-H
C. Hunter,M. A. Duggan,Q. Duan,P. Power,J. Gregoire,J. Nation
Cytopathology. 2009; 20(1): 17
[Pubmed]
11 Cytology and outcome of LSIL: cannot exclude HSIL compared to ASC-H
Hunter, C. and Duggan, MA and Duan, Q. and Power, P. and Gregoire, J. and Nation, J.
Cytopathology. 2009; 20(1): 17-26
[Pubmed]
12 Impact of ASC-H terminology on the detection of HSILs in medically underserved California women
Howell, L.P. and Gurusinghe, S. and Tabnak, F.
Diagnostic Cytopathology. 2009; 37(2): 103-110
[Pubmed]
13 Impact of ASC-H terminology on the detection of HSILs in medically underserved California women
Lydia Pleotis Howell,Sunitha Gurusinghe,Farzaneh Tabnak
Diagnostic Cytopathology. 2009; 37(2): 103
[Pubmed]
14 Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results
Bandyopadhyay, S., Austin, R.M., Dabbs, D., Zhao, C.
Archives of Pathology and Laboratory Medicine. 2008; 132(12): 1874-1881
[Pubmed]
15 Patients with negative cervical biopsies after papanicolaou test interpretations of “atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion”: comparative longitudinal follow-up
Huitron, S. and Bonvicino, A. and Fadare, O.
Annals of Diagnostic Pathology. 2008; 12(3): 187-190
[Pubmed]
16 CytoJournalæs move to the new platform: More on financial model to the support open-access charter in cytopathology, publication quality indicators, and other issues
Shidham, VB and Pitman, MB and DeMay, RM and Atkinson, BF
CytoJournal. 2008; 5(1): 15
[Pubmed]
17 Atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion: Cytohistologic correlation study with diagnostic pitfalls
Mokhtar, G.A., Roustan Delateur, N.L.D., Assiri, A.H., Gilliatt, M.A., Senterman, M., Islam, S.
Acta Cytologica. 2008; 52(2): 169-177
[Pubmed]
18 Patients with negative cervical biopsies after papanicolaou test interpretations of “atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion”: comparative longitudinal follow-up
Sonny Huitron,Amanda Bonvicino,Oluwole Fadare
Annals of Diagnostic Pathology. 2008; 12(3): 187
[Pubmed]
19 Papanicolaou test interpretations of "atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion": An investigation of requisite duration and number of colposcopic procedures to a definitive diagnosis of high-grade dysplasia in routine practice
Bonvicino, A., Huitron, S., Fadare, O.
Cancer. 2007; 111(6): 477-481
[Pubmed]
20 Should LSIL with ASC-H (LSIL-H) in cervical smears be an independent category?: A study on SurePath specimens with review of literature
Shidham, V.B. and Kumar, N. and Narayan, R. and Brotzman, G.L.
Cytojournal. 2007; 4(art no 7)
[Pubmed]
21 Evaluation and significance of hyperchromatic crowded groups(HCG) in liquid-based paps
Chivukula, M. and Austin, R.M. and Shidham, V.B.
CytoJournal. 2007; 4(1): 2
[Pubmed]
22 The best in CytoJournal: 2006
Cohen, M.B.
CytoJournal. 2007; 4(1): 12
[Pubmed]
23 Papanicolaou test interpretations of “atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion”
Amanda Bonvicino,Sonny Huitron,Oluwole Fadare
Cancer. 2007; 111(6): 477
[Pubmed]
24 Contribution of HPV sequences detection in cervical carcinoma screening | [Intérêt de la recherche des séquences virales HPV dans le dépistage du cancer du col utérin]
Noël, J.-C., Bucella, D., Fayt, I., Romero-Munoz, M.-R., Simon, P.
Annales de Pathologie. 2006; 26(5): 389-396
[Pubmed]
25 Intérêt de la recherche des séquences virales HPV dans le dépistage du cancer du col utérin
Jean-Christophe Noël,Dario Bucella,Isabelle Fayt,Maria-Rosario Romero-Munoz,Philippe Simon
Annales de Pathologie. 2006; 26(5): 389
[Pubmed]



 

Top
Previous article Next article

    

  Site Map | Copyright and Disclaimer
© 2007 - CytoJournal | A journal by Cytopathology Foundation Inc with Medknow
New version online since 1st July '08
Open Access